Latest News

SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer
Read press release
SAGA Diagnostics® Presents Real-World Pathlight™ MRD Data at ASCO GI 2026
Read More
SAGA Diagnostics’ Pathlight™ MRD Further Demonstrates Clinical Validity In TNBC Trials Presented at SABCS
Read More
SAGA Diagnostics Showcases New Pathlight MRD Data at SABCS 2025
Read More
SAGA Diagnostics® to Present at the Jefferies Global Healthcare Conference in London 2025
Read More
SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes
Read More
SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection
Read More